Providing a diverse range of perspectives from bullish to bearish, 5 analysts have published ratings on Precigen (NASDAQ:PGEN) in the last three months.
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 3 | 2 | 0 | 0 | 0 |
| Last 30D | 1 | 1 | 0 | 0 | 0 |
| 1M Ago | 0 | 0 | 0 | 0 | 0 |
| 2M Ago | 0 | 0 | 0 | 0 | 0 |
| 3M Ago | 2 | 1 | 0 | 0 | 0 |
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $8.2, with a high estimate of $14.00 and a low estimate of $4.00. A 12.77% drop is evident in the current average compared to the previous average price target of $9.40.
Decoding Analyst Ratings: A Detailed Look
An in-depth analysis of...
Login or create a forever free account to read this news
Sign up/Log in